BeeWell

Trials & centers

Ask your doctor

Pick a condition

Recruiting trials

Phase I/II Randomized Study of NBTXR3 Activated by Abscopal or RadScopal Radiation in Combination With Immunotherapy (Anti-PD-1/L-1) for Patients With Advanced Solid Malignancies

Phase 1 & 2 Recruiting

  • M D Anderson Cancer Center, Houston, Texas, United States
Official record

INFINITIVE: ImmuNotherapy For PatIeNts wIth colorecTal LIVer MEtastases

Early phase 1 Recruiting

  • RJ Zuckerberg, Lake Success, New York, United States
Official record

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Phase 1 Recruiting

  • Exelixis Clinical Site #67, Phoenix, Arizona, United States
  • Exelixis Clinical Site #1, Tucson, Arizona, United States
  • Exelixis Clinical Site #123, Palo Alto, California, United States
  • More sites
Official record

The Dragon PLC Trial (DRAGON-PLC)

Phase not listed Recruiting

  • Yale School of Medicine Hospital, New Haven, Connecticut, United States
  • Rush University Medical Center, Chicago, Illinois, United States
  • Mayo Clinic, Rochester, Minnesota, United States
  • More sites
Official record

DNP-MRSI of HCC Metabolism to Predict Therapeutic Response

Observational Recruiting

  • University of Pennsylvania, Philadelphia, Pennsylvania, United States
Official record

Therasphere® and Systemic Therapy for Patients With Hepatocellular Carcinoma That is High-risk

Phase 2 Recruiting

  • Northwestern University, Chicago, Illinois, United States
  • Northwestern Medicine Kishwaukee Hospital, DeKalb, Illinois, United States
  • Northwestern Medicine Delnor Hospital, Geneva, Illinois, United States
  • More sites
Official record

Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors

Phase 1 Recruiting

  • Start Lacn, Los Angeles, California, United States
  • START Dallas, Fort Worth, Texas, United States
  • START Mountain Region, West Valley City, Utah, United States
Official record

Novel Method to Assess Hepatic Regeneration and Predict Hepatic Related Morbidity After Partial Hepatectomy

Phase not listed Recruiting

  • Englewood Hospital, Englewood, New Jersey, United States
Official record
ClinicalTrials.gov

NCI-designated centers

Comprehensive & clinical

Alabama

Arizona

California

Colorado

Connecticut

District of Columbia

  • Georgetown Lombardi Comprehensive Cancer Center

    Washington, District of Columbia

Florida

Georgia

Hawai'i

Illinois

Indiana

  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center

    Indianapolis, Indiana

Iowa

Kansas

Kentucky

Maryland

  • Sidney Kimmel Comprehensive Cancer Center

    Baltimore, Maryland

  • University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center

    Baltimore, Maryland

Massachusetts

Michigan

Minnesota

Missouri

Nebraska

New Hampshire

New Jersey

New Mexico

  • University of New Mexico Cancer Research and Treatment Center

    Albuquerque, New Mexico

New York

North Carolina

Ohio

Oklahoma

Oregon

Pennsylvania

South Carolina

Tennessee

Texas

Utah

Virginia

Washington

  • Fred Hutchinson/University of Washington/Seattle Children's Cancer Consortium

    Seattle, Washington

Wisconsin

NCI-Designated Cancer Centers, June 10, 2026